SCHEMBL27928558

SCHEMBL27928558

Cc1c(C(N)=O)ccc(F)c1-c1cccnc1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 14/20 0.57
MKNK2 Q9HBH9 13/20 0.57
LMNA P02545 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C19 P33261 1/20 0.45
BTK Q06187 1/20 0.45
SIRT3 Q9NTG7 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
PKN1 Q16512 1/20 0.42
PKN2 Q16513 1/20 0.42
F7 P08709 1/20 0.41
F3 P13726 1/20 0.41
SARM1 Q6SZW1 1/20 0.41
SIRT2 Q8IXJ6 1/20 0.41
SIRT6 Q8N6T7 1/20 0.41
SIRT1 Q96EB6 1/20 0.41
SIRT5 Q9NXA8 1/20 0.41
SIRT4 Q9Y6E7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16462691 0.83 MKNK1 (0.50) MKNK1MKNK2LMNACYP1A2CYP3A4
SCHEMBL28785366 0.83 MKNK1 (0.53) MKNK1MKNK2LMNACYP1A2CYP3A4
SCHEMBL28784266 0.82 BCAT2 (0.44)
SCHEMBL22468503 0.82 MKNK1 (0.62) MKNK1MKNK2LMNACYP1A2CYP3A4
SCHEMBL6237458 0.77 MKNK1 (0.58) MKNK1MKNK2LMNACYP1A2CYP3A4
SCHEMBL6237449 0.77 MKNK1 (0.62) MKNK1MKNK2LMNACYP1A2CYP3A4
SCHEMBL27880990 0.76 MKNK1 (0.58) MKNK1MKNK2CYP1A2CYP3A4SIRT3
SCHEMBL17067114 0.75 MKNK1 (0.67) MKNK1MKNK2
SCHEMBL30702229 0.74 MKNK1 (0.59) MKNK1MKNK2LMNACYP1A2CYP3A4
SCHEMBL30702237 0.74 MKNK1 (0.59) MKNK1MKNK2LMNACYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101903362-B Tetrazole-substituted arylamide derivatives and their use as P2X3 and/or P2X2/3 purinergic receptor antagonists HOFFMANN LA ROCHE 2013-07-17 CN disclosed